Publikationen von 0000-0001-8530-780X
(ORCID: 0000-0001-8530-780X)

Meyer, Stefanie, Buser, Lorenz , Haferkamp, Sebastian, Berneburg, Mark, Maisch, Tim, Klinkhammer-Schalke, Monika, Pauer, Armin, Vogt, Thomas und Garbe, Claus (2023) Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I–IIA cutaneous melanoma. European Journal of Cancer 182, S. 77-86. Volltext nicht vorhanden.

Kreft, Sophia, Gesierich, Anja, Eigentler, Thomas, Franklin, Cindy, Valpione, Sara, Ugurel, Selma, Utikal, Jochen, Haferkamp, Sebastian, Blank, Christian, Larkin, James , Garbe, Claus , Schadendorf, Dirk, Lorigan, Paul und Schilling, Bastian (2019) Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma. European Journal of Cancer 116, S. 207-215. Volltext nicht vorhanden.

Ulmer, Anja, Dietz, Klaus , Werner-Klein, Melanie, Häfner, Hans-Martin, Schulz, Claudia, Renner, Philipp, Weber, Florian, Breuninger, Helmut, Röcken, Martin, Garbe, Claus , Fierlbeck, Gerhard und Klein, Christoph A. (2018) The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival. European Journal of Cancer 91, S. 1-10. Volltext nicht vorhanden.